BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33086204)

  • 21. Non-invasive distinction of non-alcoholic fatty liver disease using urinary volatile organic compound analysis: early results.
    Arasaradnam RP; McFarlane M; Daulton E; Westenbrink E; O'Connell N; Wurie S; Nwokolo CU; Bardhan KD; Savage RS; Covington JA
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):197-201. PubMed ID: 26114180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
    Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
    J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Furan and p-xylene as candidate biomarkers for prostate cancer.
    Jiménez-Pacheco A; Salinero-Bachiller M; Iribar MC; López-Luque A; Miján-Ortiz JL; Peinado JM
    Urol Oncol; 2018 May; 36(5):243.e21-243.e27. PubMed ID: 29395956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VOCs from Exhaled Breath for the Diagnosis of Hepatocellular Carcinoma.
    Sukaram T; Apiparakoon T; Tiyarattanachai T; Ariyaskul D; Kulkraisri K; Marukatat S; Rerknimitr R; Chaiteerakij R
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Volatile Organic Compounds (VOCs) in Urine via Gas Chromatography-Mass Spectrometry QTOF to Differentiate Between Localized and Metastatic Models of Breast Cancer.
    Woollam M; Teli M; Angarita-Rivera P; Liu S; Siegel AP; Yokota H; Agarwal M
    Sci Rep; 2019 Feb; 9(1):2526. PubMed ID: 30792417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volatolome of the Female Genitourinary Area: Toward the Metabolome of Cervical Cancer.
    Rodríguez-Esquivel M; Rosales J; Castro R; Apresa-García T; Garay Ó; Romero-Morelos P; Marrero-Rodríguez D; Taniguchi-Ponciano K; López-Romero R; Guerrero-Flores H; Morales B; Mendoza-Rodríguez M; Mosso-Lara D; Núñez-Nolasco I; Castro-Alba P; Meza-Toledo SE; Salcedo M
    Arch Med Res; 2018 Jan; 49(1):27-35. PubMed ID: 29681412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
    Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
    Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary volatile organic compound markers and colorectal anastomotic leakage.
    Plat VD; Bootsma BT; Neal M; Nielsen K; Sonneveld DJA; Tersteeg JJC; Crolla RMPH; van Dam DA; Cense HA; Stockmann HBAC; Covington JA; de Meij TGJ; Tuynman JB; de Boer NKH; Daams F
    Colorectal Dis; 2019 Nov; 21(11):1249-1258. PubMed ID: 31207011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable VOCs in plastic culture flasks and their potential impact on cell volatile biomarkers.
    Chu Y; Zhou J; Ge D; Lu Y; Zou X; Xia L; Huang C; Shen C; Chu Y
    Anal Bioanal Chem; 2020 Sep; 412(22):5397-5408. PubMed ID: 32564118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy.
    Wang M; Xie R; Jia X; Liu R
    Med Princ Pract; 2017; 26(4):375-380. PubMed ID: 28633145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary volatile metabolites of amygdala-kindled mice reveal novel biomarkers associated with temporal lobe epilepsy.
    Fujita A; Ota M; Kato K
    Sci Rep; 2019 Jul; 9(1):10586. PubMed ID: 31332211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics.
    Rudnicka J; Kowalkowski T; Ligor T; Buszewski B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3360-6. PubMed ID: 21982505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved quantification of livestock associated odorous volatile organic compounds in a standard flow-through system using solid-phase microextraction and gas chromatography-mass spectrometry.
    Yang X; Zhu W; Koziel JA; Cai L; Jenks WS; Laor Y; Leeuwen JH; Hoff SJ
    J Chromatogr A; 2015 Oct; 1414():31-40. PubMed ID: 26456221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of high-throughput miniaturized sorbent- and solid phase microextraction techniques combined with gas chromatography-mass spectrometry analysis for a rapid screening of volatile and semi-volatile composition of wines--a comparative study.
    Mendes B; Gonçalves J; Câmara JS
    Talanta; 2012 Jan; 88():79-94. PubMed ID: 22265473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosing Inflammatory bowel disease using noninvasive applications of volatile organic compounds: a systematic review.
    Bannaga AS; Farrugia A; Arasaradnam RP
    Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1113-1122. PubMed ID: 31657950
    [No Abstract]   [Full Text] [Related]  

  • 37. Non-Invasive Diagnosis of Diabetes by Volatile Organic Compounds in Urine Using FAIMS and Fox4000 Electronic Nose.
    Esfahani S; Wicaksono A; Mozdiak E; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2018 Dec; 8(4):. PubMed ID: 30513787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
    Ligor T; Pater Ł; Buszewski B
    J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.